Australian Society of Cytology - Pursuit of Excellence
Australian Society of Cytology

Case of the Month

December 2004 - Answer and Discussion

Papillary thyroid carcinoma arising in Hashimoto's thyroiditis


Answer

Cytological assessment of the sample revealed a Hashimoto's thyroiditis with an associated papillary carcinoma confirmed on subsequent histology one month after the FNB. Hashimoto's thyroiditis was confirmed with a raised thyroid antibody titre of 1600.

Cytological Description:

  • Polymorphous population of lymphocytes
  • Occasional plasma cells and tingible-body macrophages
  • Lymphoid tangles
  • Reactive follicle cells some with oncocytic metaplasia
  • Intimate association of lymphocytes with follicle cells
  • 1 slide showed numerous crowded sheets, fragments and microfollicles. Some strips of columnar cells.
  • Nuclear chromatin in these groups -finely granular & dust-like
  • Intranuclear vacuoles & longitudinal grooves seen within some pale nuclei

    

Histology:

The total thyroidectomy revealed a 9mm focus of papillary carcinoma in association with chronic lymphocytic thyroiditis / Hashimoto's thyroiditis

Figure 7 Figure 8 Figure 9 Figure 10

Discussion

Clinical characteristics of Hashimoto's thyroiditis

  • Painless bilateral, symmetrical, firm or rubbery lobular diffuse enlargement of the thyroid.
  • Disease of women F/M 10:1.
  • >Caucasian women 30-50 years of age.
  • 70 -80% of patients show signs of hypothyroidism.
  • Defined by the presence of antithyroid antibodies, > antimicrosomal antibodies and the presence of a lymphocytic infiltrate.
  • 90% of patients will be positive for antithyroglobulin or antimicrosomal (antiperoxidase) antibodies.

Clinical characteristics of papillary thyroid carcinoma

  • Most common thyroid carcinoma
  • Any age, mean = 40, > females
  • Associated in patients with hx of radiation exposure.
  • Common presentation - solitary "cold" nodule.
  • May have a adjacent palpable cervical lymph node.
  • Multicentricity (bilateralism) in 20% due to intrathyroid metastases.

Pitfalls in clinical presentation

  • Hashimoto's thyroiditis may present as a single nodule
  • Co-existence of neoplasms namely non Hodgkin's lymphoma of B-cell type and papillary thyroid carcinoma (PTC)
  • PTC not always solitary nodule

Cytological findings in Hashimoto's thyroiditis

  • Polymorphous population of lymphocytes, occasional plasma cells and tingible-body macrophages.
  • Lymphoid tangles.
  • Scant to absent colloid.
  • Oncocytes and reactive follicle cells
  • Punctate nuclear chromatin
  • Intimate association of follicle cells with lymphocytes

Cytological findings of papillary carcinoma

  • Cellular smears unless cystic (common)
  • Papillary tissue fragments +/- fibrovascular core
  • Syncytial cell aggregates, sheets of epithelial cells with a distinct anatomical border (well defined edge), strips or single columnar cells, polygonal cells
  • Nuclear crowding and overlapping
  • Enlarged oval nuclei, with fine dust-like chromatin
  • Intranuclear vacuoles and grooves
  • Dense cytoplasm, with distinct cell borders
  • Viscous ropey colloid ('chewing gum')
  • Psammoma bodies (25%), multinculeated giant cells
  • >Lymphoid infiltrate

Diagnostic features in PTC

  • Papillae and psammoma bodies diagnostic of PTC, not always seen.
  • Nuclear features are critical - "Orphan Annie" or optically clear nucleus
  • Nuclear grooves occasionally seen in non-papillary neoplasms and non-neoplastic thyroid lesions. Not often associated with other thyroid cancers.
  • When seen in abundance (>=20%) can be considered a reliable criterion for the diagnosis of PTC

    

Incidence of Hashimoto's thyroiditis with PTC

  • Thyroid stimulating hormone (TSH) implicated in the formation of PTC, with raised levels often demonstrated in Hashimoto's thyroiditis (HT).
  • Incidence of PTC with associated Hashimoto's thyroiditis 0.5% to 32% - solitary 'cold' nodule.
  • Prognosis in patients with PTC + HT is better than PTC alone

Diagnosis of PTC by other ancillary techniques

  • Immunohistochemical stains :
    Expression of CK 19, HBME-1, Galectin3 & p63
  • Molecular profile studies:
    RET/PTC1 & 3 gene re-arrangements.

Nuclear PTC-like changes in altered thyroid follicle cells in HT

  • Nuclear enlargement, overlapping, cleared chromatin, membrane changes, grooves and inclusions seen in 1/3 of HT cases

Similarities in papillary thyroid cancer and Hashimoto's thyroiditis on a molecular level

  • Focal expression of proteins associated with PTC ie CK19, HMBE-1, GAL3 & CITED1 in the altered follicle cells of HT, not in the oncocytes
  • Shows a link between molecular, genetic and morphological features between these altered follicle cells and PTC
  • ? PTC associated genes are activated in HT

p63 expression in papillary carcinoma & Hashimoto's thyroiditis

  • P63 expression negative in normal thyroid tissue, nodular goitres & oncocytic follicular adenomas.
  • P63 +ve foci commonly expressed in Hashimoto's thyroiditis (78.8% of cases) and PTC (81.8%)
  • Weak or no expression in follicular & medullary carcinomas.
  • Could p63 expression therefore be a pathobiologic link between PTC & Hashimoto's thyroiditis?

Expression of the RET/PTC Fusion Genes as a Marker For PTC & Hashimoto's thyroiditis

  • RET/PTC gene rearragements are highly specific markers of early stages of papillary carcinoma, in particular oncogenes RET/PTC1 & RET/PTC3.
  • RET/PTC1 - classical, diffuse PTC
  • RET/PTC3 - follicular/solid variant, short latent period, aggressive course eg Chernobyl
  • RET/PTC1 & RET/PTC3 oncogene rearrangement reported in Hashimoto's thyroiditis patients. (95%, 58%)

Does Hashimoto's thyroiditis share features with early papillary carcinoma?

  • Patients with Hashimoto's thyroiditis are at increased risk of PTC
  • Overlap in immunohistochemical staining patterns
  • Similarities in molecular expression between Hashimoto's thyroiditis & PTC. HT has been found to harbour a genetic re-arrangement strongly associated with PTC

CONCLUSION

  • The link between Hashimoto's thyroiditis & papillary carcinoma is likely but not conclusive.
  • Be aware of the co-existence of the two conditions
  • Long term follow-up of patients with HT to enable early diagnosis of thyroid cancer

References:

  1. Diagnostic Cytopathology. Edited by Winifred Gray. Churchill Livingstone. Pp520-535
  2. Segal K et al. Hashimoto’s thyroiditis and carcinoma of the thyroid gland. Int Surg. 1985 Jul-Sept;70(3):205-9
  3. Ott RA et al. The incidence of thyroid carcinoma in Hashimoto’s thyroiditis. Am Surg. 1987 Aug;53(8):442-5
  4. Pisanu A et al. Coexisting Hashimoto’s thyroiditis with differentiated thyroid cancer and benign thyroid diseases: indications for thyroidectomy. Chir Ital. 2003 May-Jun;55(3):265-72
  5. Di Pasquale M et al. Pathologic features of Hashimoto’s–associated papillary carcinomas. Hum Pathol. 2001 Jan;32(1):24-30.
  6. Prasad, ML et al. Hashimoto’s thyroiditis with papillary thyroid carcinoma (PTC)-like nuclear alterations express molecular markers of PTC. Histopathology 2004, 45, pp39-46
  7. Burstein, David E et al Immunohistochemical Detection of p53 Homolog p63 in solid cell nests, papillary thyroid carcinoma and Hashimoto’s thyroiditis: A stem cell hypothesis of papillary carcinoma oncogenesis. Human Pathology Vol 35, No. 4 (April 2004) pp465-473
  8. Cheung CC et al. Immunochemical diagnosis of papillary thyroid carcinoma. Modern Pathol 2001 Apr;14 (4):pp338-42
  9. Sheils OM et al. Ret/PTC-1 activation in Hashimoto’s thyroiditis. Int J Surg Pathol. 2000 Jul;8(3):185-189
  10. Arif S et al. Hashimoto’s thyroiditis shares features with early papillary thyroid carcinoma. Histopathology. 2002 Oct;41(4):357-62
  11. Williams ED et al. Thyroid carcinoma after Chernobyl latent period, morphology and aggressiveness. Br J Cancer. 2004 Jun 1;90(11):2219-24
  12. Feinmesser M et al. HLA-DR expression and lymphocytic infiltration in metastatic and non-metastatic papillary carcinoma of the thyroid. Eur J Surg Oncol. 1996 Oct;22(5):494-501
  13. Gasbarri A et al Detection and molecular characterisation of thyroid cancer precursor lesions in a specific subset of Hashimoto’s thyroiditis. Br J Cancer. 2004 Aug 3.
  14. Berho M and Suster S. Clear nuclear changes in Hashimoto’s thyroiditis. A clinicopathologic study of 12 cases. Ann Clin Lab Sci. 1995 Nov-Dec;25(6):513-21.
  15. Chan JK and Saw D. the grooved nucleus. A useful diagnostic criterion of papillary carcinoma of the thyroid. Am J Surg Pathol. 1986 Oct;10(10);672-9
  16. Yang GC and Greenbaum E. Clear nuclei of papillary thyroid carcinoma conspicuous in fine needle aspiration and intraoperative smears processed by ultrafast papanicolaou stain. Mod Pathol. 1997 Jun;10(6):552-5
  17. Nasser SM et al. Fine-needle aspiration biopsy of papillary thyroid carcinoma: diagnostic utility of cytokeratin 19 immunostaining. Cancer. 2000 Oct 25;90(5):307-11.

Return to top of page

Email MavilPro